Grace Therapeutics, Inc. Share Price & Technical Analysis
GRCE · $2.20 (-1.79%)
Healthcare / Biotechnology
$2.20
-1.79%
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topi…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-4% return in May, 5% avg return in past 3 year May month.
-26% return in 2026, 31% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | 19% | 10% | -53% | -4% | – | – | – | – | – | – | – | -26% |
| 25 | -13% | -9% | -23% | 8% | 4% | 7% | 0% | 3% | 0% | 7% | 3% | 9% | -4% |
| 24 | -11% | 32% | 0% | -15% | -4% | 7% | -7% | -4% | 15% | 7% | 10% | 16% | 47% |
| 23 | 43% | -28% | -10% | 4% | 14% | 3% | -16% | -16% | 40% | -14% | -8% | 38% | 50% |
| 22 | -8% | -4% | 9% | -15% | -3% | -12% | -4% | -2% | -29% | 3% | -26% | 7% | -84% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$35.13M
P/E ratio
—
52W high
$5.18
52W low
$1.79
Volume
2,59,833
Beta
0.32
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Grace Therapeutics, Inc. share price today?
- Grace Therapeutics, Inc. (GRCE) last traded around $2.20 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GRCE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GRCE. Download the app for real-time alerts.
- How can I analyze Grace Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.